{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:24:03Z","timestamp":1792009443351,"version":"4.4.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often in association with endometriosis) and closely mimics a variety of other tumor types that occur in these locations. While it shows significant morphologic, immunohistochemical, and molecular homology with cervical mesonephric adenocarcinoma, there are many clinicopathologic features that suggest m\u00fcllerian derivation, and this is now well established. As research on MLA has accumulated, questions have emerged about optimal practices for the diagnosis of these challenging tumors. In 2022, faculty at M.D. Anderson Cancer Center convened the Mesonephric-like Adenocarcinoma (MLA) Consortium, comprised of international pathologists, gynecologic oncologists, medical oncologists, radiation oncologists, and basic science investigators with expertise in MLA, with the goals to enhance understanding of these tumors, refine diagnostic criteria, improve treatment options, and facilitate research collaborations. An initial review from the consortium was published in 2025, and included diagnostic recommendations from the group\u2019s pathologists. Controversies remain, however, about the morphologic, immunohistochemical, and molecular criteria that should be used to establish a diagnosis of MLA. Herein, the pathologists from the MLA Consortium provide a comprehensive evaluation of the literature on MLA diagnostic criteria, address ongoing controversies in this area, and provide practical guidance for pathologists considering this entity.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001150","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:00:11Z","timestamp":1764100811000},"page":"57-78","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium"],"prefix":"10.1097","volume":"45","author":[{"given":"Anne M.","family":"Mills","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Euscher","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Mirkovic","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Kolin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"How","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L.","family":"Ring","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A Comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study","volume":"45","author":"Pors","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PAP.0000000000000342","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: from morphologic observations to a well-characterized carcinoma with aggressive clinical behavior","volume":"29","author":"McCluggage","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PAS.0000000000001766","article-title":"Extrauterine mesonephric-like neoplasms: expanding the morphologic spectrum","volume":"46","author":"Deolet","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/PAS.0000000000002039","article-title":"Extrauterine mesonephric-like carcinoma: a comprehensive single institution study of 33 cases","volume":"47","author":"Euscher","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2025.04.583","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: pathologic diagnosis, clinical outcomes, and novel therapeutics","volume":"197","author":"Ring","year":"2025","journal-title":"Gynecol Oncol"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/PAS.0000000000001873","article-title":"Mesonephric-like endometrial carcinoma: results from immunohistochemical screening of 300 endometrial carcinomas and carcinosarcomas for this often overlooked and potentially aggressive entity","volume":"46","author":"Mills","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"100657","DOI":"10.1016\/j.gore.2020.100657","article-title":"Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: a case report and review of the literature","volume":"34","author":"Seay","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/his.15393","article-title":"Papillary and ductal patterns of mesonepahric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas","volume":"86","author":"Akbari","year":"2025","journal-title":"Histopathology"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/his.14892","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas","volume":"82","author":"Mirkovic","year":"2023","journal-title":"Histopathology"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"747","DOI":"10.21873\/cgp.20357","article-title":"Mesonephric-like carcinosarcoma of the uterine corpus: clinicopathological, molecular and prognostic characteristics in comparison with uterine mesonephric-like adenocarcinoma and conventional endometrial carcinosarcoma","volume":"19","author":"Park","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAS.0000000000002368","article-title":"Clinicopathologic and molecular characterization of gynecologic carcinosarcomas with a mesonephric-like carcinomatous component","volume":"49","author":"Mendoza","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.21873\/anticanres.15053","article-title":"Dedifferentiated mesonephric-like adenocarcinoma of the uterine corpus","volume":"41","author":"Choi","year":"2021","journal-title":"Anticancer Res"},{"key":"R22-20251215","first-page":"2042","article-title":"Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive immunohistochemical analyses using markers for mesonephric, endometrioid and serous tumors","volume":"11","author":"Kim","year":"2021","journal-title":"Diagn Basel Switz"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.21873\/cgp.20338","article-title":"Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases","volume":"19","author":"Kim","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"R24-20251215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/his.15308","article-title":"SOX17 expression in mesonephric-like adenocarcinomas and mesonephric remnants\/hyperplasia of the female genital tract: expanding its utility as a M\u00fcllerian biomarker","volume":"85","author":"Zhang","year":"2024","journal-title":"Histopathology"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/his.15312","article-title":"Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry","volume":"86","author":"Tahir","year":"2025","journal-title":"Histopathology"},{"key":"R26-20251215","first-page":"326","article-title":"Mesonephric-like adenocarcinoma of the ovary: clinicopathological and molecular characteristics","volume":"12","author":"Koh","year":"2022","journal-title":"Diagn Basel Switz"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/PGP.0000000000000976","article-title":"Comprehensive Immunohistochemical analysis of mesonephric marker expression in low-grade endometrial endometrioid carcinoma","volume":"43","author":"Lee","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"e12389","DOI":"10.1002\/2056-4538.12389","article-title":"Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2","volume":"10","author":"K\u00f6bel","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1016\/j.gore.2020.100652","article-title":"Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin","volume":"34","author":"Lin","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"911695","DOI":"10.3389\/fonc.2022.911695","article-title":"Mesonephric-like adenocarcinoma of uterine corpus: a clinicopathological and targeted genomic profiling study in a single institution","volume":"12","author":"Ma","year":"2022","journal-title":"Front Oncol"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"101049","DOI":"10.1016\/j.gore.2022.101049","article-title":"Somatic mutation analysis of mesonephric-like adenocarcinoma and associated putative precursor lesions: insight into pathogenesis and potential molecular treatment targets","volume":"42","author":"Arslanian","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"R35-20251215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.6217","article-title":"Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix","volume":"262","author":"Kommoss","year":"2024","journal-title":"J Pathol"},{"key":"R36-20251215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2024.01.015","article-title":"Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: a single-center experience with molecular characterization, treatment, and oncologic outcomes","volume":"182","author":"Praiss","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a M\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R38-20251215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian Combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a M\u00fcllerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R39-20251215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a M\u00fcllerian duct lineage: a case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn Pathol"},{"key":"R40-20251215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-020-01012-z","article-title":"Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis","volume":"15","author":"Dundr","year":"2020","journal-title":"Diagn Pathol"},{"key":"R41-20251215","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/his.15136","article-title":"The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis","volume":"84","author":"Angelico","year":"2024","journal-title":"Histopathology"},{"key":"R42-20251215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00428-023-03522-9","article-title":"Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant \u03b2-catenin expression, and concurrent FGFR2 and CTNNB1 mutations: a case report","volume":"484","author":"Xu","year":"2024","journal-title":"Virchows Arch Int J Pathol"},{"key":"R43-20251215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/10668969231183631","article-title":"Ovarian mesonephric-like adenocarcinoma with recurrent liver metastases: a case report with analysis of therapeutic molecular targets","volume":"32","author":"Sugitani","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"R44-20251215","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/10668969231213390","article-title":"Mixed mesonephric-like adenocarcinoma, clear cell carcinoma, and endometrioid carcinoma arising from an endometriotic cyst","volume":"32","author":"Nagase","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"R45-20251215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PGP.0000000000000991","article-title":"Ovarian mesonephric-like adenocarcinoma recurring with a rhabdomyosarcoma component: a case report","volume":"43","author":"Yamamoto","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R46-20251215","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1158\/1078-0432.CCR-23-2819","article-title":"Clinical and genomic landscape of RAS mutations in gynecologic cancers","volume":"30","author":"Son","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R47-20251215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PGP.0000000000001070","article-title":"Synchronous bilateral ovarian carcinomas with right mesonephric-like adenocarcinoma and left high-grade serous carcinoma: a case report and review of the literature","volume":"44","author":"Maharjan","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R48-20251215","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.3390\/curroncol31090378","article-title":"Ovarian mesonephric-like adenocarcinoma: its prevalence in a japanese high-volume cancer center and a literature review on therapeutic targets","volume":"31","author":"Ogawa","year":"2024","journal-title":"Curr Oncol Tor Ont"},{"key":"R49-20251215","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/10668969241308206","article-title":"Mesonephric-like adenocarcinomas, an underdiagnosed rare type of gynecological malignancy associated with aggressive clinical behaviors: a series of 4 patients from single institution","volume":"33","author":"Niu","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"R50-20251215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAS.0000000000001403","article-title":"c-KIT analysis and targeted molecular sequencing of mesonephric carcinomas of the female genital tract","volume":"44","author":"Pors","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R51-20251215","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"R52-20251215","first-page":"e25098","article-title":"Not your typical adenocarcinoma: a case of mesonephric adenocarcinoma of the cervix with fibroblast growth factor receptor 2 (FGFR2) mutation","volume":"14","author":"Devarashetty","year":"2022","journal-title":"Cureus"},{"key":"R53-20251215","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-\u03b2","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R54-20251215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.humpath.2018.08.018","article-title":"Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma","volume":"86","author":"Patel","year":"2019","journal-title":"Hum Pathol"},{"key":"R56-20251215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5858\/arpa.2020-0432-OA","article-title":"Female adnexal tumor of probable Wolffian origin","volume":"146","author":"Hou","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R57-20251215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000001677","article-title":"A distinctive adnexal (usually paratubal) neoplasm often associated with Peutz-Jeghers syndrome and characterized by STK11 alterations (STK11 adnexal tumor): a report of 22 cases","volume":"45","author":"Bennett","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R58-20251215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAP.0000000000000460","article-title":"STK11 adnexal tumor: exploring the association with Peutz-Jeghers syndrome and its distinction from morphologic mimickers","volume":"32","author":"Bennett","year":"2025","journal-title":"Adv Anat Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:05:50Z","timestamp":1765814750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001150","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"2025-09-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}